Study Evaluating Changes In Mammographic Breast Density

NCT00774267 · clinicaltrials.gov ↗

COMPLETED

Status

507

Enrollment

INDUSTRY

Sponsor class

Conditions

Osteoporosis

Interventions

DRUG: BZA 20 mg/CE 0.45 mg
DRUG: BZA 20 mg/CE 0.625 mg
DRUG: Raloxifene 60 mg
DRUG: Placebo

Sponsor

Pfizer